Welcome and Keynote Lecture: Immunotherapy—Lessons Learned From Melanoma for Application to GI Malignancies
Siwen Hu-Lieskovan, MD, PhD
University of California, Los Angeles Medical Center
Conclusions:
• lmmunotherapy for cancer has the potential to provide durable benefit to a wide array of patients.
• Rational combination strategies to improve efficacy will rely on
-- • A clear understanding of the heterogeneity of intrinsic & extrinsic immune resistant mechanisms that exists in each pt.
-- • Successful development of predictive biomarkers
-- • Collaborative effort of academia, industry and regulatory authorities